We are inviting you to take part in a research study, designed to learn more about how investigational inhalers affect the ability to breathe during exercise.
The ATHLOS Study will enroll about 180 participants with COPD at study centers around the world. The study will include 7 visits and 1 follow up visit to a study center in your location, over the duration of the study, about 14 weeks. This study involves taking the combination medication twice daily, through the use of an investigational inhaler (similar to a puffer).
There is no cost to take part in the ATHLOS Study. No health insurance is required.
You may qualify for the ATHLOS Study if you:
- Are between the ages of 40 to 80 years old
- Have a diagnosis of moderate to severe COPD
- Are a current or former smoker
- Are currently using a daily inhaler for management of your COPD symptoms (not including an inhaler used for flare ups)
All study-related care, including the combination medication is provided at no cost
Sign Up
What happens if I sign up? We will match you to a research study center in your area that needs volunteers with COPD or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if qualified.
If you think you might like to participate in the ATHLOS Study or would like more information, please enter your information below so we can see if you may qualify and can contact you about the study. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
About COPD
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation due to airway abnormalities typically caused by significant exposure to tobacco smoke or other harmful particles or gases and can be influenced by other personal factors including abnormal lung development.1
Chronic obstructive pulmonary disease is a long-term, chronic inflammatory lung disease that causes obstructed airflow from the lungs, making it difficult for you to breathe.1
Symptoms of COPD may include:2
- Difficulty breathing
- Coughing
- Bringing up mucus
- Wheezing
- Chest tightness
- Frequent colds and flu
Long-term exposure to things that irritate your lungs, such as smoking or using pipes, are the most common cause of COPD. Additionally, if you are around people who smoke or use tobacco products, you may be exposed to second hand smoke3, which can also play a role.
Currently, there is no cure for COPD. Many people who are diagnosed with chronic obstructive pulmonary disease choose to stop using the irritants that caused their condition, such as smoking or tobacco use. The goal of current treatments is to ease the symptoms associated with the condition.
Frequently Asked Questions
What is a research study?
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are research studies important?
A research study is the process by which new and innovative medications, interventions and treatments are approved and brought to market, so people can live happier and healthier lives. Even over-the-counter medications, such as NSAIDs (nonsteroidal anti-inflammatory drugs such as ASPIRIN®, naproxen, and ibuprofen), you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
What is the purpose of the ATHLOS Study?
The ATHLOS Study is designed to learn more about how investigational inhalers affect the ability to breathe during exercise.
What will the ATHLOS Study involve?
The ATHLOS Study will enroll about 180 participants with COPD at study centers around the world. The study will include approximately 7 visits to a study center in your area over the duration of the 14-week study. This study involves taking the combination medication twice daily, through the use of investigational inhalers (similar to a puffer).
Will I be receiving compensation?
Volunteers who qualify to take part in the study may receive compensation up to 74. Please discuss this with the study team when they contact you.
Is there a cost to participate?
There is no cost to participate in the ATHLOS Study. If you qualify, all study-related care, including the investigational inhaler will be provided at no cost.
What else do I need to consider?
The research team will be able to explain more about what the ATHLOS Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study center?
We match you to a study center within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decide you no longer want your information stored, you can opt out and we will delete your details.
About the ATHLOS Study
The ATHLOS Study will enroll about 180 participants with COPD at study centers around the world.
The study will include 7 visits to a study center in your location over the duration of the study, about 14 weeks.
Participants will receive all study-related care, including from a dedicated medical team at no cost, including the investigational inhalers and reimbursement of rescue medication.
The ATHLOS Study is designed to learn more about how investigational inhalers affect the ability to breathe in during exercise.
Who can take part in the ATHLOS Study?
You may qualify for the ATHLOS Study if you:
- Are between the ages of 40 to 80 years old
- Have a diagnosis of moderate to severe COPD
- Are a current or former smoker
- Are currently using a daily inhaler for management of your COPD symptoms (not including an inhaler used for flare ups)
All study-related care, including the investigational inhaler is provided at no cost.
Please click here to download a handout that will direct you to a series of videos that explain the ATHLOS study further, including an introduction to clinical research, and what to expect if you decide to participate.
